RNI:JSEReinet Investments S.C.A. Analysis
Data as of 2026-06-27 - not real-time
ZAC 45,387.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Reinet Investments is trading below its 20‑day simple moving average, with the price currently around ZAc 45,387 versus the 20‑day SMA of roughly ZAc 46,994, suggesting short‑term weakness. The RSI sits at 29, deep in oversold territory, while the MACD histogram has turned positive, hinting at a potential technical bounce. However, the broader trend remains bearish, and the 30‑day volatility is elevated at nearly 40%, indicating a choppy price environment. On the valuation side, the forward P/E of about 150 dwarfs the industry average of 17, flagging significant overvaluation despite a modest price‑to‑book of 0.65. Dividend yield is modest at 1.8% but the sustainability is doubtful given a negative trailing EPS and only a forward EPS of ZAc 3.02, with a payout ratio around 50%. The recent announcement of a share‑buyback programme provides a positive catalyst, but the company’s profit margin remains negative and cash generation is limited.
Overall, the stock presents a mixed picture: technical indicators suggest a short‑term rebound possibility, yet fundamental metrics point to overvaluation and earnings weakness. Investors should weigh the upside from the buy‑back against the high forward multiple and earnings volatility before deciding on exposure.
Overall, the stock presents a mixed picture: technical indicators suggest a short‑term rebound possibility, yet fundamental metrics point to overvaluation and earnings weakness. Investors should weigh the upside from the buy‑back against the high forward multiple and earnings volatility before deciding on exposure.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI deep oversold indicating potential rebound
- Positive MACD histogram suggesting bullish momentum
- Share buy‑back announcement boosting confidence
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward P/E far above industry average
- Uncertain dividend sustainability
- High short‑term volatility
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Significant overvaluation relative to earnings outlook
- Negative profit margins and limited cash flow
- Elevated volatility and weak fundamental profile
Key Metrics & Analysis
Financial Health
Revenue Growth770.20%
Profit Margin-9.33%
P/E Ratio150.3
P/B Ratio0.7
Op. Cash FlowZAC306.0M
Industry P/E16.9
Technical Analysis
TrendBearish
RSI29.1
SupportZAC 45,216.00
ResistanceZAC 51,186.00
MA 20ZAC 46,994.20
MA 50ZAC 52,694.16
MA 200ZAC 54,360.39
MACDBullish
VolumeStable
Fear & Greed Index88.55
Valuation
Fair ValueZAC 4,123.14
GradeOvervalued
TypeGrowth
Dividend Yield1.80%
Risk Assessment
Beta-0.05
Volatility39.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.